Published by Persistence MarketResearch
Posted on September 27, 2021
5 min readLast updated: February 2, 2026
The Pulmonary Fibrosis Treatment Market is set to grow at a 6.2% CAGR, reaching $2.7 Bn by 2031, driven by rising IPF cases and new therapies.
The Pulmonary Fibrosis Treatment Market will witness a CAGR of 6.2%, reaching US$ 2.7 Bn between 2021-2031. With medical IoT implying the use of wearable monitors, devices, and various integrated applications regarding healthcare needs, the healthcare vertical is bound to scale new-fangled heights in the upcoming period. This is what the healthcare vertical would all be in the next 10 years.
Monotherapy is cost-effective and gives deliverable action directly to the site of action in a few minutes, and is said to be a safe and effective method for treating idiopathic pulmonary fibrosis (IPF). According to Persistence Market Research (PMR), request for pulmonary fibrosis treatment is predicted to increase, enabling the market to surpass US$ 2.7 Bn by 2021. Over the coming years, rising cases of IPF will support the expansion of the market.
Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/30070
High number of research & development projects, increasing investments, and favorable regulatory policies are some other factors supporting growth of the market for pulmonary fibrosis treatment. Majority of the population living with pulmonary fibrosis is being treated with traditional corticosteroid combination drugs with limited efficacy. With the arrival of new novel therapies, unaddressed populations in middle- and lower-income countries, as well as developed countries, can offer significant revenue generation opportunities.
Key Take aways from Market Study
Get To Touch in our Expert @ https://www.persistencemarketresearch.com/ask-an-expert/30070
“Rising prevalence of idiopathic pulmonary fibrosis and importance of early diagnosis are creating growth opportunities for market players in the long term,” says a Persistence Market Research analyst.
Collaborations and Product Approval – Imperative Strategy for Market Players
Leading market players are strengthening their market position through collaborations with various other organizations.Global leading companies are focusing on research activities and approvals for increased market penetration.
Access Full Report @ https://www.persistencemarketresearch.com/checkout/30070
What else is in the report?
Persistence Market Research offers a unique perspective and actionable insights on the pulmonary fibrosis treatment market in its latest study, presenting historical demand assessment of 2016 – 2020 and projections for 2021 – 2031, based on therapy (monotherapy, combination therapy and symptomatic treatment), indication (idiopathic pulmonary fibrosis (IPF), familial PF, and others), and distribution channel (hospital pharmacies, retail pharmacies, and mail order pharmacies), across seven key regions of the world.
Access Related Reports:
Cell and Tissue Culture Supplies Market:
According to a new market report published by Persistence Market Research “Global Market Study on Cell and Tissue Culture Supplies: Asia to Witness Highest Growth by 2020” the global cell and tissue culture supplies market was valued at USD 16,322.7 million in 2014 and is expected to grow at a CAGR of 9.5% from 2014 to 2020, to reach an estimated value of USD 28,108.3 million in 2020.
Biologics Safety Testing Market:
A recently published report by Persistence Market Research projects that the global market for biologics safety testing will soar at a robust CAGR of 8.8% over the forecast period, 2017-2022. The report anticipates that approx. US$ 4.36 Bn worth of biologics safety testing products & services will be utilized globally by the end of 2022.
Medical Marijuana Market:
The medical marijuana market is anticipated to record a year-over-year growth rate of 15.9% and reach a market value of US$ 39,891.2 Mn by 2026.
Recombinant Cell Culture Supplements:
According to a latest report published by Persistence Market Research, the global recombinant cell culture supplements market was valued at US$ 441 Mn in 2020, and is predicted to witness an impressive CAGR of over 6% during the forecast period (2021 – 2031).
About Us:
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com
The post The Period From 2021-2031 To Witness Hybrid (Organic And Inorganic) Transition For Pulmonary Fibrosis Treatment Market (Reaching US$ 2.7 Bn) appeared first on Lake Shore Gazette.
The article discusses the growth and trends in the Pulmonary Fibrosis Treatment Market from 2021 to 2031.
The market is projected to reach $2.7 billion by 2031.
Rising IPF cases, new therapies, and collaborations are key growth drivers.
Explore more articles in the Research Reports category
